Smith & Nephew plc vs Vanguard Information Technology Index Fund ETF — how do they compare? Smith & Nephew plc trades at $27.96 (market cap $11.62B), while Vanguard Information Technology Index Fund ETF trades at $120.5. The key difference: Smith & Nephew plc pays a 2.86% dividend while Vanguard Information Technology Index Fund ETF pays none, and Vanguard Information Technology Index Fund ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | VGT | |
|---|---|---|
Market Cap | $11.62B | — |
Sector | Health | — |
52-Week High | $38.53 | $125.77 |
52-Week Low | $27.80 | $83.59 |
Enterprise Value | $14.66B | — |
Dividend Yield | 2.86% | — |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
VGT trades at $121.05, showing modest daily weakness with a 0.18% decline. Technical indicators signal a bullish trend with strong moving average support, while oscillators remain neutral. Recent institutional buying activity from firms like Arcus Capital Partners and Guardian Wealth Advisors highlights strong professional interest in the technology ETF.
The ETF's concentrated exposure to AI leaders like Nvidia and Broadcom provides growth potential but also concentration risk. While technical momentum remains positive, investors should monitor semiconductor sector volatility and competitive pressures within the technology landscape that could impact future returns.
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →